February 2024
08 Sep 2024
The global muscle stimulator market size was evaluated at USD 718.8 million in 2022 and is expected to rise to USD 941 million by 2030, growing at a strong CAGR of 3.42 percent during the forecast period from 2022 To 2030.
The muscle stimulator market is extending internationally. The significant market drivers of the muscle stimulator market are the expansion in the medical care financial plans and an ascent in the interest in different wellness items. With rising abundance and expansion in the removal pay, particularly valid for the developing business sectors like China and India, the interest in muscle stimulators is expanding. One more significant market driver in this section is the developing ubiquity of muscle stimulators among physiotherapists, who utilize such gadgets for relief from discomfort and muscle recuperation is additionally helping the extension of the muscle stimulator market.
Report Highlights:
Muscle Stimulator Market Report Scope:
Report Coverage | Details |
Market Revenue in 2023 | USD 743.41 Million |
Projected Forecast Revenue in 2030 | USD 941 Million |
Growth Rate from 2022 to 2030 | CAGR of 3.42% |
Largest Market | North America |
Base Year | 2022 |
Forecast Period | 2022 To 2030 |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Regional Snapshot:
North America is supposed to hold a huge portion of the overall industry because of the developing medical services consumption for the development and improvement of clinical gadgets, expanding outer muscle problems, and the presence of a deep-rooted medical services framework.
As per the Arthritis Society, 2022, around 20% of the populace, that is 1 out of 5 individuals, have joint pain in Canada. Torment influences a more prominent number of US residents than diabetes, coronary illness, and malignant growth joined. Torment is referred to as the most well-known justification for US residents to get to the medical services framework. It is the main source of inability and a significant supporter of medical care costs. The tremendous weight of target sicknesses is supporting the market development in the locale.
Besides, the send-offs in the locale give the district a state of the art over others. In June 2022, the FDA conceded De Novo's freedom to a remedy nerve feeling gadget, the IB-Stim gadget, which is a solitary utilize electrical nerve stimulator for the decrease of useful stomach torment, made by Innovative Health Solutions. The gadget is planned for use by youths and youngsters with touchy gut conditions, in the mix with different treatments.
Market Dynamics:
Drivers:
The surge in the sports activities along with the need for the performance enhancement by the players
The development of the worldwide muscle stimulator market is driven by expansion in the ubiquity of sports combined with a flood sought after wellness items, ascend in the geriatric populace, and the upsurge in the frequency of outer muscle and neuromuscular problems. Also, ascend in familiarity with electrical muscle excitement treatments and expansion in inclination among physiotherapists about electrical muscle feeling contribute toward the development of the muscle stimulator market. On the other hand, the improvement of remote compact muscle stimulators is supposed to offer worthwhile open doors during the figure time frame.
Restraints:
The increasing cost of muscle stimulators leading to the shifting of consumers toward cost-effective options
Notwithstanding, the significant expense of muscle stimulators is empowering clients to pick less expensive elective treatments like yoga, needle therapy, and fragrant healing. In agricultural nations, for example, China and India, yoga and needle therapy are liked because of the accommodation and adaptability of those treatments. Additionally, the absence of rules for the utilization of muscle stimulators is adding to the expanded use of elective treatments. This reception of elective treatments among the patient populace is limiting the market development.
Opportunities:
Growing advancements in biologics and quality of stimulators
The advances in sophisticated biologics, increased purchasing power, increased healthcare expenditure, and worldwide access to high-quality medications for middle and poor-class families are all contributing factors. On the other hand, due to enhanced treatment regarding early treatment and screening of rheumatoid arthritis, the global rheumatoid arthritis drugs market is predicted to rise quickly and shift the market outlook. As a result, growing advancements in biologics are creating lucrative opportunities for the growth of the global rheumatoid arthritis drugs market.
Challenges:
Breakage of the supply chain of stimulators to the customers
The pandemic emphatically affects the market as numerous respiratory muscle stimulators are getting sent off used to treat patients with COVID-19. A few market players encountered an income drop in the triggers stage, because of the COVID. For example, in the financial year 2020-2022, Neurometrix Inc. enlisted a decline in net deals by 20% The drop in deals of Altis single-entry point slings and different merchandise was generally because of the abrogation of elective tasks and medicines in the U.S. because of the COVID-19 episode. Also, because of the COVID-19 episode, the elective methods outside the U.S. were deferred in a few nations.
Recent Developments:
Major Key Players:
Market Segmentation:
By Product Type
By Modality
By Application
By End-user
Buy this Research Report@ https://www.precedenceresearch.com/checkout/2192
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
February 2024
October 2023
July 2023
July 2022